JP2005237384A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005237384A5 JP2005237384A5 JP2005076974A JP2005076974A JP2005237384A5 JP 2005237384 A5 JP2005237384 A5 JP 2005237384A5 JP 2005076974 A JP2005076974 A JP 2005076974A JP 2005076974 A JP2005076974 A JP 2005076974A JP 2005237384 A5 JP2005237384 A5 JP 2005237384A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- zinc finger
- seq
- type
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims description 448
- 108090000623 proteins and genes Proteins 0.000 claims description 448
- 230000014509 gene expression Effects 0.000 claims description 175
- 229920000023 polynucleotide Polymers 0.000 claims description 120
- 239000002157 polynucleotide Substances 0.000 claims description 120
- 239000000523 sample Substances 0.000 claims description 107
- 230000035897 transcription Effects 0.000 claims description 77
- 150000001413 amino acids Chemical class 0.000 claims description 62
- 230000027455 binding Effects 0.000 claims description 48
- 102000004965 antibodies Human genes 0.000 claims description 45
- 108090001123 antibodies Proteins 0.000 claims description 45
- 238000009739 binding Methods 0.000 claims description 35
- 229920001850 Nucleic acid sequence Polymers 0.000 claims description 33
- 230000001105 regulatory Effects 0.000 claims description 32
- 230000036961 partial Effects 0.000 claims description 28
- 238000009396 hybridization Methods 0.000 claims description 19
- 230000000295 complement Effects 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- 230000002194 synthesizing Effects 0.000 claims description 15
- 230000002103 transcriptional Effects 0.000 claims description 15
- 238000003786 synthesis reaction Methods 0.000 claims description 14
- 229920000272 Oligonucleotide Polymers 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 229920001405 Coding region Polymers 0.000 claims description 6
- 230000000692 anti-sense Effects 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000001900 immune effect Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 229910052725 zinc Inorganic materials 0.000 description 309
- 239000011701 zinc Substances 0.000 description 309
- 210000004027 cells Anatomy 0.000 description 196
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 179
- 229920002676 Complementary DNA Polymers 0.000 description 177
- 239000002299 complementary DNA Substances 0.000 description 143
- 150000003751 zinc Chemical compound 0.000 description 130
- 239000000243 solution Substances 0.000 description 107
- 201000010099 disease Diseases 0.000 description 103
- 238000004458 analytical method Methods 0.000 description 97
- 210000001519 tissues Anatomy 0.000 description 64
- 238000006243 chemical reaction Methods 0.000 description 58
- 230000000694 effects Effects 0.000 description 58
- 241000282414 Homo sapiens Species 0.000 description 54
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 46
- 108020004999 Messenger RNA Proteins 0.000 description 46
- 229920002106 messenger RNA Polymers 0.000 description 46
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 44
- 239000003814 drug Substances 0.000 description 41
- 102000003995 transcription factors Human genes 0.000 description 40
- 108090000464 transcription factors Proteins 0.000 description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 36
- 238000003752 polymerase chain reaction Methods 0.000 description 34
- 150000001875 compounds Chemical class 0.000 description 33
- 230000004069 differentiation Effects 0.000 description 29
- 102000005962 receptors Human genes 0.000 description 29
- 108020003175 receptors Proteins 0.000 description 29
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 28
- 238000005259 measurement Methods 0.000 description 27
- 201000011510 cancer Diseases 0.000 description 26
- 230000018109 developmental process Effects 0.000 description 25
- -1 ATF-3 Proteins 0.000 description 24
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 24
- 108010069411 transcription factor S-II Proteins 0.000 description 24
- 238000011161 development Methods 0.000 description 23
- 239000011780 sodium chloride Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 20
- 102000003886 Glycoproteins Human genes 0.000 description 19
- 108090000288 Glycoproteins Proteins 0.000 description 19
- 102000018697 Membrane Proteins Human genes 0.000 description 19
- 108010052285 Membrane Proteins Proteins 0.000 description 19
- 102100019730 TP53 Human genes 0.000 description 19
- 101710026335 TP53 Proteins 0.000 description 19
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 19
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 19
- 229940079593 drugs Drugs 0.000 description 19
- 230000019491 signal transduction Effects 0.000 description 19
- 230000001058 adult Effects 0.000 description 18
- 239000011534 wash buffer Substances 0.000 description 18
- 230000000638 stimulation Effects 0.000 description 17
- 210000004556 Brain Anatomy 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 230000014616 translation Effects 0.000 description 16
- 102100002692 NFKB1 Human genes 0.000 description 15
- JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 14
- 241000590002 Helicobacter pylori Species 0.000 description 14
- 229940037467 Helicobacter pylori Drugs 0.000 description 14
- 230000002708 enhancing Effects 0.000 description 14
- 239000003446 ligand Substances 0.000 description 14
- 238000001243 protein synthesis Methods 0.000 description 14
- 102100012486 JUN Human genes 0.000 description 13
- 230000001605 fetal Effects 0.000 description 13
- 238000005406 washing Methods 0.000 description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 12
- 101700086102 NFKB1 Proteins 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 102100012170 TCEA1 Human genes 0.000 description 12
- 230000004663 cell proliferation Effects 0.000 description 12
- 210000004748 cultured cells Anatomy 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000008363 phosphate buffer Substances 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 101700071021 SETD2 Proteins 0.000 description 11
- 102100000940 SETD2 Human genes 0.000 description 11
- 108010018242 Transcription Factor AP-1 Proteins 0.000 description 11
- 230000024245 cell differentiation Effects 0.000 description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
- 230000001939 inductive effect Effects 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 11
- 108060001251 CD34 Proteins 0.000 description 10
- 102100016492 CD34 Human genes 0.000 description 10
- 210000004292 Cytoskeleton Anatomy 0.000 description 10
- 229940088598 Enzyme Drugs 0.000 description 10
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 102000031025 DNA-Binding Proteins Human genes 0.000 description 9
- 108091000102 DNA-Binding Proteins Proteins 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 9
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 9
- 102000012132 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 9
- 102000020497 RNA-Binding Proteins Human genes 0.000 description 9
- 108091022184 RNA-Binding Proteins Proteins 0.000 description 9
- 102100007015 SERPINE1 Human genes 0.000 description 9
- 102100018660 ZNF85 Human genes 0.000 description 9
- 101700003826 ZNF85 Proteins 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 238000001415 gene therapy Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 230000035772 mutation Effects 0.000 description 9
- 229920002312 polyamide-imide Polymers 0.000 description 9
- 230000003248 secreting Effects 0.000 description 9
- 208000008787 Cardiovascular Disease Diseases 0.000 description 8
- 210000003754 Fetus Anatomy 0.000 description 8
- 230000036740 Metabolism Effects 0.000 description 8
- 208000001132 Osteoporosis Diseases 0.000 description 8
- 102100016147 R3HCC1L Human genes 0.000 description 8
- 101710032342 R3HCC1L Proteins 0.000 description 8
- 102000007312 Recombinant Proteins Human genes 0.000 description 8
- 108010033725 Recombinant Proteins Proteins 0.000 description 8
- 102100018661 ZNF84 Human genes 0.000 description 8
- 101700002878 ZNF84 Proteins 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 8
- 230000003321 amplification Effects 0.000 description 8
- 230000032823 cell division Effects 0.000 description 8
- 200000000018 inflammatory disease Diseases 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000035786 metabolism Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 230000032258 transport Effects 0.000 description 8
- 210000003855 Cell Nucleus Anatomy 0.000 description 7
- 206010017758 Gastric cancer Diseases 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 210000003734 Kidney Anatomy 0.000 description 7
- LRMQCJCMKQSEJD-UHFFFAOYSA-N Oligo B Polymers O1C(N2C3=NC=NC(N)=C3N=C2)C(OC)C(OC(=O)C=2C=C3C4(OC(=O)C3=CC=2)C2=CC=C(O)C=C2OC2=CC(O)=CC=C24)C1COP(O)(=O)OC1C(C(O2)N3C(N=C(N)C(C)=C3)=O)OCC12COP(O)(=O)OC(C1OC)C(COP(O)(=O)OC2C3(COP(O)(=O)OC4C(C(OC4COP(O)(=O)OC4C(C(OC4COP(O)(=O)OC4C(C(OC4COP(O)(=O)OC4C5(COP(O)(=O)OC6C(C(OC6COP(O)(=O)OC6C7(COP(O)(=O)OC8C(C(OC8COP(O)(=O)OC8C9(CO)COC8C(O9)N8C(N=C(N)C(C)=C8)=O)N8C(NC(=O)C=C8)=O)OC)COC6C(O7)N6C(N=C(N)C(C)=C6)=O)N6C(N=C(N)C=C6)=O)OC)COC4C(O5)N4C(N=C(N)C(C)=C4)=O)N4C5=NC=NC(N)=C5N=C4)OC)N4C5=C(C(NC(N)=N5)=O)N=C4)OC)N4C5=C(C(NC(N)=N5)=O)N=C4)OC)COC2C(O3)N2C(N=C(N)C(C)=C2)=O)OC1N1C=CC(=O)NC1=O LRMQCJCMKQSEJD-UHFFFAOYSA-N 0.000 description 7
- 108010016731 PPAR gamma Proteins 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 7
- 230000033228 biological regulation Effects 0.000 description 7
- 238000003501 co-culture Methods 0.000 description 7
- 230000002860 competitive Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 230000003834 intracellular Effects 0.000 description 7
- 230000001575 pathological Effects 0.000 description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
- 201000011549 stomach cancer Diseases 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000004568 DNA-binding Effects 0.000 description 6
- 206010012601 Diabetes mellitus Diseases 0.000 description 6
- 102000033147 ERVK-25 Human genes 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 210000002744 Extracellular Matrix Anatomy 0.000 description 6
- 208000007882 Gastritis Diseases 0.000 description 6
- 108010061833 Integrases Proteins 0.000 description 6
- 210000004072 Lung Anatomy 0.000 description 6
- 210000001616 Monocytes Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 210000002997 Osteoclasts Anatomy 0.000 description 6
- 102100005149 ZNF91 Human genes 0.000 description 6
- 101700011488 ZNF91 Proteins 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 239000012496 blank sample Substances 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 101700068999 nap1 Proteins 0.000 description 6
- 230000000926 neurological Effects 0.000 description 6
- 210000002569 neurons Anatomy 0.000 description 6
- 230000002148 osteoclast Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000014621 translational initiation Effects 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl dihydrogen phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 5
- 206010059512 Apoptosis Diseases 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 108020004461 Double-Stranded RNA Proteins 0.000 description 5
- 210000001161 Embryo, Mammalian Anatomy 0.000 description 5
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 5
- 210000002540 Macrophages Anatomy 0.000 description 5
- 229910015621 MoO Inorganic materials 0.000 description 5
- 241000699660 Mus musculus Species 0.000 description 5
- 208000008469 Peptic Ulcer Diseases 0.000 description 5
- 102000014128 RANK Ligand Human genes 0.000 description 5
- 108010025832 RANK Ligand Proteins 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 210000004291 Uterus Anatomy 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 5
- 210000000653 nervous system Anatomy 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 235000013024 sodium fluoride Nutrition 0.000 description 5
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Inorganic materials [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 102100000628 ATF2 Human genes 0.000 description 4
- 101700079605 ATF2 Proteins 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 4
- 210000000988 Bone and Bones Anatomy 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 4
- 230000033616 DNA repair Effects 0.000 description 4
- 101700036614 GBF1 Proteins 0.000 description 4
- 102100010464 GBF1 Human genes 0.000 description 4
- 101700019698 GNL1 Proteins 0.000 description 4
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- 229920002459 Intron Polymers 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 102000007999 Nuclear Proteins Human genes 0.000 description 4
- 108010089610 Nuclear Proteins Proteins 0.000 description 4
- 102000011931 Nucleoproteins Human genes 0.000 description 4
- 108010061100 Nucleoproteins Proteins 0.000 description 4
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 4
- 230000025458 RNA interference Effects 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N Spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 102100014526 TBC1D8 Human genes 0.000 description 4
- 101710035852 TBC1D8 Proteins 0.000 description 4
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 102100013734 ZNF44 Human genes 0.000 description 4
- 101700045832 ZNF44 Proteins 0.000 description 4
- 102100001628 ZNF816 Human genes 0.000 description 4
- 101710017715 ZNF816 Proteins 0.000 description 4
- 102100018662 ZNF83 Human genes 0.000 description 4
- 101700045282 ZNF83 Proteins 0.000 description 4
- 101700070836 ZNFP Proteins 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 230000003042 antagnostic Effects 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000004097 bone metabolism Effects 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000000875 corresponding Effects 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 230000001146 hypoxic Effects 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 108010045030 monoclonal antibodies Proteins 0.000 description 4
- 102000005614 monoclonal antibodies Human genes 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 230000001172 regenerating Effects 0.000 description 4
- 230000002987 rna-interference Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 208000007502 Anemia Diseases 0.000 description 3
- 108060001651 CLP1 Proteins 0.000 description 3
- 102100003507 CLP1 Human genes 0.000 description 3
- 101710009500 CYP4F2 Proteins 0.000 description 3
- 102100009526 CYP4F2 Human genes 0.000 description 3
- 241000252203 Clupea harengus Species 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 206010012689 Diabetic retinopathy Diseases 0.000 description 3
- 210000000981 Epithelium Anatomy 0.000 description 3
- 101700062930 HTF1 Proteins 0.000 description 3
- 210000000987 Immune System Anatomy 0.000 description 3
- 206010021425 Immune system disease Diseases 0.000 description 3
- 102000004851 Immunoglobulin G Human genes 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 102000004310 Ion Channels Human genes 0.000 description 3
- 108090000862 Ion Channels Proteins 0.000 description 3
- 210000004185 Liver Anatomy 0.000 description 3
- 206010027175 Memory impairment Diseases 0.000 description 3
- 108010057466 NF-kappa B Proteins 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 101700049205 PEG10 Proteins 0.000 description 3
- 108050004610 Pointed domain Proteins 0.000 description 3
- 102000016157 Pointed domain Human genes 0.000 description 3
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 3
- 206010039073 Rheumatoid arthritis Diseases 0.000 description 3
- 108050008861 SH3 domain Proteins 0.000 description 3
- 102000000395 SH3 domain Human genes 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 101710006588 TCF4 Proteins 0.000 description 3
- 102100006739 TCF4 Human genes 0.000 description 3
- 101710036661 TSPYL1 Proteins 0.000 description 3
- 210000001550 Testis Anatomy 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 208000001756 Virus Disease Diseases 0.000 description 3
- 102100018163 ZNF184 Human genes 0.000 description 3
- 101710002224 ZNF184 Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 101710025562 alphaTub85E Proteins 0.000 description 3
- 108010093001 anti-IgG Proteins 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 201000011529 cardiovascular cancer Diseases 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000003966 growth inhibitor Substances 0.000 description 3
- 235000019514 herring Nutrition 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000000126 in silico method Methods 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000000302 ischemic Effects 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 238000010841 mRNA extraction Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000000520 microinjection Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 230000000865 phosphorylative Effects 0.000 description 3
- 108091008117 polyclonal antibodies Proteins 0.000 description 3
- 230000002829 reduced Effects 0.000 description 3
- 108091007521 restriction endonucleases Proteins 0.000 description 3
- 210000001995 reticulocyte Anatomy 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000004218 vascular function Effects 0.000 description 3
- 230000003612 virological Effects 0.000 description 3
- 235000021307 wheat Nutrition 0.000 description 3
- OHCQJHSOBUTRHG-KGGHGJDLSA-N (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-5-yl acetate Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- XMINXPSYULINQV-UHFFFAOYSA-N 1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(hydroxymethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxa Chemical compound NC(=O)CNC(=O)C(C(C)CC)NC(=O)C1CCCN1C(=O)C1NC(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(N)CSSC1 XMINXPSYULINQV-UHFFFAOYSA-N 0.000 description 2
- 101710025088 66 Proteins 0.000 description 2
- 101700042601 ATF4 Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108020004491 Antisense DNA Proteins 0.000 description 2
- OXDZADMCOWPSOC-UHFFFAOYSA-N Argiprestocin Chemical compound N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 OXDZADMCOWPSOC-UHFFFAOYSA-N 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 101710040446 CD40 Proteins 0.000 description 2
- 101700024634 CDK16 Proteins 0.000 description 2
- 210000001233 CDP Anatomy 0.000 description 2
- 108010065376 COUP Transcription Factor I Proteins 0.000 description 2
- 101700046803 CPRF1 Proteins 0.000 description 2
- 101700054054 CPRF2 Proteins 0.000 description 2
- 101700001910 CPRF3 Proteins 0.000 description 2
- 101700033282 CREM Proteins 0.000 description 2
- 102100005505 CREM Human genes 0.000 description 2
- 102100004047 CYP1B1 Human genes 0.000 description 2
- 101710036800 CYP1B1 Proteins 0.000 description 2
- 101710009493 CYP4F3 Proteins 0.000 description 2
- 102000003922 Calcium Channels Human genes 0.000 description 2
- 108090000312 Calcium Channels Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 210000001638 Cerebellum Anatomy 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 210000001612 Chondrocytes Anatomy 0.000 description 2
- OHCQJHSOBUTRHG-ZYIXGEAZSA-N Coleonol Natural products O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@H](O)CCC1(C)C OHCQJHSOBUTRHG-ZYIXGEAZSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 210000001072 Colon Anatomy 0.000 description 2
- 210000002808 Connective Tissue Anatomy 0.000 description 2
- 229920000453 Consensus sequence Polymers 0.000 description 2
- ZWIADYZPOWUWEW-XVFCMESISA-N Cytidine diphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 2
- 102000033193 DDIT3 Human genes 0.000 description 2
- 101700032231 DDIT3 Proteins 0.000 description 2
- 108020001019 DNA Primers Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 101700082870 EGR1 Proteins 0.000 description 2
- 101700083561 EGR2 Proteins 0.000 description 2
- 101700039426 EGR3 Proteins 0.000 description 2
- 101700077295 ELK1 Proteins 0.000 description 2
- 102100010275 ELK1 Human genes 0.000 description 2
- 102100010267 ELK4 Human genes 0.000 description 2
- 101700013756 ELK4 Proteins 0.000 description 2
- 101710043593 ENSANGG00000000822 Proteins 0.000 description 2
- 102100016655 ERN1 Human genes 0.000 description 2
- 101700036757 ERN1 Proteins 0.000 description 2
- 101700014948 ERN2 Proteins 0.000 description 2
- 102100002070 FOS Human genes 0.000 description 2
- 108060001038 FOS Proteins 0.000 description 2
- 210000002458 Fetal Heart Anatomy 0.000 description 2
- 108090000123 Fos-related antigen 1 Proteins 0.000 description 2
- 102000003817 Fos-related antigen 1 Human genes 0.000 description 2
- 108090000045 G-protein coupled receptors Proteins 0.000 description 2
- 102000003688 G-protein coupled receptors Human genes 0.000 description 2
- 102100006503 GABPA Human genes 0.000 description 2
- 101700037531 GABPA Proteins 0.000 description 2
- 101700048985 GATA1 Proteins 0.000 description 2
- 102100010478 GATA1 Human genes 0.000 description 2
- 101700001555 GATA2 Proteins 0.000 description 2
- 101700021558 GATA3 Proteins 0.000 description 2
- 101700002184 GATA4 Proteins 0.000 description 2
- 101700028799 GBF2 Proteins 0.000 description 2
- 101700071059 GBF3 Proteins 0.000 description 2
- 108060001039 GCN4 Proteins 0.000 description 2
- 101700077877 GNL2 Proteins 0.000 description 2
- 101710023322 GOT2 Proteins 0.000 description 2
- 102100006245 GOT2 Human genes 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 108010070675 Glutathione Transferase family Proteins 0.000 description 2
- 102100016995 HNF1A Human genes 0.000 description 2
- 101700018864 HNF1A Proteins 0.000 description 2
- 101700004272 HOX9 Proteins 0.000 description 2
- 102100020039 HPGDS Human genes 0.000 description 2
- 102100003632 HSF1 Human genes 0.000 description 2
- 101700082442 HSF2 Proteins 0.000 description 2
- 102100001003 HSF2 Human genes 0.000 description 2
- 101710002911 HSFA1E Proteins 0.000 description 2
- 101710004116 HSFB2B Proteins 0.000 description 2
- 101710026271 HSPBAP1 Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 229940088597 Hormone Drugs 0.000 description 2
- 108060003800 Hsf Proteins 0.000 description 2
- 102000015434 Humanized Monoclonal Antibodies Human genes 0.000 description 2
- 108010064750 Humanized Monoclonal Antibodies Proteins 0.000 description 2
- 101700085586 IRE1A Proteins 0.000 description 2
- 101700019719 IRE1B Proteins 0.000 description 2
- 102100013278 IRF2 Human genes 0.000 description 2
- 101700001385 IRF2 Proteins 0.000 description 2
- 101700019115 ISOT Proteins 0.000 description 2
- 102000017182 Ikaros Transcription Factor Human genes 0.000 description 2
- 108010013958 Ikaros Transcription Factor Proteins 0.000 description 2
- 108090000890 Interferon Regulatory Factor-1 Proteins 0.000 description 2
- 102000004289 Interferon Regulatory Factor-1 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 108020004391 Introns Proteins 0.000 description 2
- 108060001040 JUN Proteins 0.000 description 2
- 101700060851 JUNB Proteins 0.000 description 2
- 101700030553 JUND Proteins 0.000 description 2
- 101700028281 Jra Proteins 0.000 description 2
- 102100006525 KLF4 Human genes 0.000 description 2
- 101700048573 KLF4 Proteins 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229920001320 Leader sequence (mRNA) Polymers 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 101700081363 MAFG Proteins 0.000 description 2
- 101710007526 MAP3K14 Proteins 0.000 description 2
- 101710004426 MYBL1 Proteins 0.000 description 2
- 102100003551 MYBL1 Human genes 0.000 description 2
- 102100002207 MZF1 Human genes 0.000 description 2
- 101700055875 MZF1 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010035768 MyoD Protein Proteins 0.000 description 2
- 101710044747 NFATC1 Proteins 0.000 description 2
- 102100000563 NFATC1 Human genes 0.000 description 2
- 101700064339 NFE2 Proteins 0.000 description 2
- 102100007978 NFE2 Human genes 0.000 description 2
- 102100017283 NFYC Human genes 0.000 description 2
- 101700004898 NFYC Proteins 0.000 description 2
- 101710007431 NHLH1 Proteins 0.000 description 2
- 102100005399 NHLH1 Human genes 0.000 description 2
- 101700023263 NIT2 Proteins 0.000 description 2
- 101710012901 NKX2-1 Proteins 0.000 description 2
- 101710012898 NKX2-2 Proteins 0.000 description 2
- 102100018288 NKX2-2 Human genes 0.000 description 2
- 101710012882 NKX2-5 Proteins 0.000 description 2
- 102100018406 NR2F1 Human genes 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 101700068201 OPI1 Proteins 0.000 description 2
- 101710003000 ORF1/ORF2 Proteins 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 108010049358 Oncogene Protein p65(gag-jun) Proteins 0.000 description 2
- 108010084438 Oncogene Protein v-maf Proteins 0.000 description 2
- 108010054076 Oncogene Proteins v-myb Proteins 0.000 description 2
- 101710004306 Os04g0364800 Proteins 0.000 description 2
- 101710044170 Os09g0525500 Proteins 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 210000001672 Ovary Anatomy 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 108050009469 PAS domain Proteins 0.000 description 2
- 102000002131 PAS domain Human genes 0.000 description 2
- 101700037331 PAX1 Proteins 0.000 description 2
- 101700011681 PAX3 Proteins 0.000 description 2
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 2
- 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
- 101710006193 POU2F2 Proteins 0.000 description 2
- 102100013577 POU2F2 Human genes 0.000 description 2
- 108010028924 PPAR alpha Proteins 0.000 description 2
- 101700014840 PTPRH Proteins 0.000 description 2
- 101700044505 PUB33 Proteins 0.000 description 2
- 101700045570 PUB34 Proteins 0.000 description 2
- 101700046887 PUB35 Proteins 0.000 description 2
- 101700066160 PUB51 Proteins 0.000 description 2
- 101700067511 PUB52 Proteins 0.000 description 2
- 101700068819 PUB53 Proteins 0.000 description 2
- 101700086326 PUB70 Proteins 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N Phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 102000001253 Protein Kinases Human genes 0.000 description 2
- 108060006633 Protein Kinases Proteins 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- 108010087776 Proto-Oncogene Proteins c-myb Proteins 0.000 description 2
- 102000009096 Proto-Oncogene Proteins c-myb Human genes 0.000 description 2
- 102000004409 RNA helicases Human genes 0.000 description 2
- 108090000944 RNA helicases Proteins 0.000 description 2
- 230000004570 RNA-binding Effects 0.000 description 2
- 101700064749 RXRA Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- 229920001785 Response element Polymers 0.000 description 2
- 102000002278 Ribosomal Proteins Human genes 0.000 description 2
- 108010000605 Ribosomal Proteins Proteins 0.000 description 2
- 101700033344 SCP2 Proteins 0.000 description 2
- 102000014400 SH2 domains Human genes 0.000 description 2
- 108050003452 SH2 domains Proteins 0.000 description 2
- 101700073916 SIM2 Proteins 0.000 description 2
- 102200046300 SLX4IP E74A Human genes 0.000 description 2
- 101700077397 SOX5 Proteins 0.000 description 2
- 101700030874 SOX9 Proteins 0.000 description 2
- 108060007882 SRY Proteins 0.000 description 2
- 108010081691 STAT2 Transcription Factor Proteins 0.000 description 2
- 102000004265 STAT2 Transcription Factor Human genes 0.000 description 2
- 102100019667 STAT3 Human genes 0.000 description 2
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 2
- 108010019992 STAT4 Transcription Factor Proteins 0.000 description 2
- 102000005886 STAT4 Transcription Factor Human genes 0.000 description 2
- 101710035401 STAT5A Proteins 0.000 description 2
- 102100002982 STAT5A Human genes 0.000 description 2
- 101710035391 STAT5B Proteins 0.000 description 2
- 102100013397 STAT5B Human genes 0.000 description 2
- 108010011005 STAT6 Transcription Factor Proteins 0.000 description 2
- 102000013968 STAT6 Transcription Factor Human genes 0.000 description 2
- 102000013598 Signal recognition particle protein Human genes 0.000 description 2
- 108010051611 Signal recognition particle protein Proteins 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 229920000978 Start codon Polymers 0.000 description 2
- 210000002784 Stomach Anatomy 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 108060008048 TAF1 Proteins 0.000 description 2
- 108060008091 TBP Proteins 0.000 description 2
- 101710036135 TCF3 Proteins 0.000 description 2
- 101700000944 TEF Proteins 0.000 description 2
- 101700075137 TGA1A Proteins 0.000 description 2
- 101700024203 TGA1B Proteins 0.000 description 2
- 101700014606 TITF1 Proteins 0.000 description 2
- 102100005028 TTF1 Human genes 0.000 description 2
- 101700052851 TTF1 Proteins 0.000 description 2
- 241001441722 Takifugu rubripes Species 0.000 description 2
- 102000003978 Tissue plasminogen activator Human genes 0.000 description 2
- 108090000373 Tissue plasminogen activator Proteins 0.000 description 2
- 210000003437 Trachea Anatomy 0.000 description 2
- 229960001727 Tretinoin Drugs 0.000 description 2
- 206010046766 Uterine cancer Diseases 0.000 description 2
- 108010064636 Vasotocin Proteins 0.000 description 2
- 108060009539 YAP1 Proteins 0.000 description 2
- 101700046316 YBX1 Proteins 0.000 description 2
- 101700016268 YY1 Proteins 0.000 description 2
- 102100013551 ZNF135 Human genes 0.000 description 2
- 101710002463 ZNF135 Proteins 0.000 description 2
- 101710003247 ZNF208 Proteins 0.000 description 2
- 102100006157 ZNF22 Human genes 0.000 description 2
- 101700039030 ZNF22 Proteins 0.000 description 2
- 102100001622 ZNF823 Human genes 0.000 description 2
- 101710017727 ZNF823 Proteins 0.000 description 2
- 102100015229 ZSCAN2 Human genes 0.000 description 2
- 101710011526 ZSCAN2 Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 239000003816 antisense DNA Substances 0.000 description 2
- 230000001580 bacterial Effects 0.000 description 2
- 230000037348 biosynthesis Effects 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000001413 cellular Effects 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 108091006028 chimera Proteins 0.000 description 2
- 230000002759 chromosomal Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229960005188 collagen Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 101700080124 erg-1 Proteins 0.000 description 2
- 201000004101 esophageal cancer Diseases 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000003260 fluorescence intensity Methods 0.000 description 2
- 229930002911 forskolin Natural products 0.000 description 2
- 101700019721 fosB1 Proteins 0.000 description 2
- 101700026037 fosB2 Proteins 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- 101700051568 gN Proteins 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 230000002068 genetic Effects 0.000 description 2
- 101710024127 gpbA Proteins 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 101700052395 ire-1 Proteins 0.000 description 2
- 201000010982 kidney cancer Diseases 0.000 description 2
- 238000007169 ligase reaction Methods 0.000 description 2
- 230000000670 limiting Effects 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 108010075796 liver regeneration factor 1 Proteins 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 101710040730 mat1-Mc Proteins 0.000 description 2
- 101710012683 mecom-a Proteins 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000000790 osteoblast Effects 0.000 description 2
- 230000001402 polyadenylating Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000003449 preventive Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000022983 regulation of cell cycle Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 108010038912 retinoid X receptors Proteins 0.000 description 2
- 102000034577 retinoid X receptors Human genes 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 108020001302 sepiapterin reductase Proteins 0.000 description 2
- 102000004222 sepiapterin reductase Human genes 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
- 230000025366 tissue development Effects 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 201000006134 tongue cancer Diseases 0.000 description 2
- LBCZOTMMGHGTPH-UHFFFAOYSA-N 2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCO)C=C1 LBCZOTMMGHGTPH-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 101700027113 AREA Proteins 0.000 description 1
- 101700049688 ARNT Proteins 0.000 description 1
- 101700042788 ASCC1 Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 210000001593 Adipocytes, Brown Anatomy 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 210000004100 Adrenal Glands Anatomy 0.000 description 1
- 210000004727 Amygdala Anatomy 0.000 description 1
- 244000105975 Antidesma platyphyllum Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 210000001130 Astrocytes Anatomy 0.000 description 1
- 101710019231 BS Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 210000003651 Basophils Anatomy 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000000601 Blood Cells Anatomy 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 102100002974 CDKN1A Human genes 0.000 description 1
- 101710022308 CDKN1A Proteins 0.000 description 1
- 101700021703 CDP Proteins 0.000 description 1
- 108091010503 CONSTANS family Proteins 0.000 description 1
- 102100006435 CSF3 Human genes 0.000 description 1
- 102000033156 CUX1 Human genes 0.000 description 1
- 101700041765 CUX1 Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 210000001159 Caudate Nucleus Anatomy 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
- 102000010991 Chaperonin Cpn60 Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 210000000349 Chromosomes Anatomy 0.000 description 1
- 241000500138 Ciona savignyi Species 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 210000000877 Corpus Callosum Anatomy 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 229940095074 Cyclic AMP Drugs 0.000 description 1
- 108050006400 Cyclins Proteins 0.000 description 1
- 102000016736 Cyclins Human genes 0.000 description 1
- 101710009495 Cyp4f1 Proteins 0.000 description 1
- 101710009514 Cyp4f14 Proteins 0.000 description 1
- 101710009496 Cyp4f4 Proteins 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000003849 Cytochrome P450 Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101700011961 DPOM Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 102000004420 EC 2.7.3.2 Human genes 0.000 description 1
- 108010042126 EC 2.7.3.2 Proteins 0.000 description 1
- 229940022766 EGTA Drugs 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 210000003372 Endocrine Glands Anatomy 0.000 description 1
- 210000002889 Endothelial Cells Anatomy 0.000 description 1
- 210000003979 Eosinophils Anatomy 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 210000003238 Esophagus Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 210000003499 Exocrine Glands Anatomy 0.000 description 1
- 229920000665 Exon Polymers 0.000 description 1
- 229920002760 Expressed sequence tag Polymers 0.000 description 1
- 102000024572 Fos family Human genes 0.000 description 1
- 108091011796 Fos family Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100011343 GLB1 Human genes 0.000 description 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 1
- 229960004666 Glucagon Drugs 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N Glucagonum Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 210000003714 Granulocytes Anatomy 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101700051166 HLF Proteins 0.000 description 1
- 102100019110 HSPBAP1 Human genes 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 206010019375 Helicobacter infection Diseases 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 210000001320 Hippocampus Anatomy 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 210000004408 Hybridomas Anatomy 0.000 description 1
- 102000018358 Immunoglobulins Human genes 0.000 description 1
- 108060003951 Immunoglobulins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229940047124 Interferons Drugs 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000024570 Jun family Human genes 0.000 description 1
- 108091011794 Jun family Proteins 0.000 description 1
- 210000002510 Keratinocytes Anatomy 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101700069276 LIMA1 Proteins 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108060001084 Luciferase family Proteins 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 102100002319 MARCHF7 Human genes 0.000 description 1
- 101710044246 MARCHF7 Proteins 0.000 description 1
- 101710029649 MDV043 Proteins 0.000 description 1
- 101710024180 MW0072 Proteins 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L Magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 210000000138 Mast Cells Anatomy 0.000 description 1
- 210000003593 Megakaryocytes Anatomy 0.000 description 1
- 210000003584 Mesangial Cells Anatomy 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 210000002027 Muscle, Skeletal Anatomy 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- 210000004413 Myocytes, Cardiac Anatomy 0.000 description 1
- 108091007229 NSP3 Papain-like protease domain Proteins 0.000 description 1
- 101700080605 NUC1 Proteins 0.000 description 1
- 210000000440 Neutrophils Anatomy 0.000 description 1
- 240000008962 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108020003217 Nuclear RNA Proteins 0.000 description 1
- 108009000118 Nuclear Receptors Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 101700061424 POLB Proteins 0.000 description 1
- 108010044210 PPAR-beta Proteins 0.000 description 1
- 101710002259 PPP1R12C Proteins 0.000 description 1
- 210000002741 Palatine Tonsil Anatomy 0.000 description 1
- 102000035443 Peptidases Human genes 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 210000003819 Peripheral blood mononuclear cell Anatomy 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920000582 Polyisocyanurate Polymers 0.000 description 1
- 210000002307 Prostate Anatomy 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 101700054624 RF1 Proteins 0.000 description 1
- 108010065868 RNA polymerase SP6 Proteins 0.000 description 1
- 101710005015 RNASEL Proteins 0.000 description 1
- 102100005870 RNH1 Human genes 0.000 description 1
- 101700064599 RNH1 Proteins 0.000 description 1
- 229920000970 Repeated sequence (DNA) Polymers 0.000 description 1
- 210000003705 Ribosomes Anatomy 0.000 description 1
- 108010003581 Ribulose-Bisphosphate Carboxylase Proteins 0.000 description 1
- 101700073136 SCRN1 Proteins 0.000 description 1
- 102100016728 SIM2 Human genes 0.000 description 1
- 102100004476 SIRPA Human genes 0.000 description 1
- 101710024246 SIRPA Proteins 0.000 description 1
- 101700079512 SPH Proteins 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 229920000972 Sense strand Polymers 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- 210000002536 Stromal Cells Anatomy 0.000 description 1
- 101710039294 TAP50 Proteins 0.000 description 1
- 101710040537 TNF Proteins 0.000 description 1
- 101700073473 TPT1 Proteins 0.000 description 1
- 229920001949 Transfer RNA Polymers 0.000 description 1
- 108060008759 UBR1 Proteins 0.000 description 1
- 108020003635 Untranslated Regions Proteins 0.000 description 1
- 229920000146 Untranslated region Polymers 0.000 description 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 102100005213 ZNF132 Human genes 0.000 description 1
- 101710002498 ZNF132 Proteins 0.000 description 1
- 102100013552 ZNF136 Human genes 0.000 description 1
- 101710002444 ZNF136 Proteins 0.000 description 1
- 102100013560 ZNF345 Human genes 0.000 description 1
- 101710014695 ZNF345 Proteins 0.000 description 1
- SIIZPVYVXNXXQG-KGXOGWRBSA-N [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-hydroxyoxolan-2-yl]methyl [(2R,4R,5R)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate Polymers C1=NC2=C(N)N=CN=C2N1[C@@H]1O[C@H](COP(O)(=O)OC2[C@@H](O[C@H](COP(O)(O)=O)[C@H]2O)N2C3=NC=NC(N)=C3N=C2)[C@@H](O)[C@H]1OP(O)(=O)OCC([C@@H](O)[C@H]1O)OC1N1C(N=CN=C2N)=C2N=C1 SIIZPVYVXNXXQG-KGXOGWRBSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic Effects 0.000 description 1
- 102000038129 antigens Human genes 0.000 description 1
- 108091007172 antigens Proteins 0.000 description 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N cAMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000000711 cancerogenic Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000002317 cardiac myocyte Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002999 depolarising Effects 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000534 elicitor Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000002538 fungal Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037240 fusion proteins Human genes 0.000 description 1
- 201000002406 genetic disease Diseases 0.000 description 1
- 238000010358 genetic engineering technique Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000009424 haa Nutrition 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 108010023112 leukotriene B4 20-hydroxylase Proteins 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 102000027675 major histocompatibility complex family Human genes 0.000 description 1
- 108091007937 major histocompatibility complex family Proteins 0.000 description 1
- 108091022076 maltose binding proteins Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 229960000060 monoclonal antibodies Drugs 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 210000004255 neuroglia Anatomy 0.000 description 1
- 108010087904 neutravidin Proteins 0.000 description 1
- 101700006494 nucA Proteins 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108060005645 nusG Proteins 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000026731 protein phosphorylation Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 230000006884 regulation of angiogenesis Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 230000001177 retroviral Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 102000034377 signal transducing proteins Human genes 0.000 description 1
- 108091006008 signal transducing proteins Proteins 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000000392 somatic Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 108060007856 spt5 Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 102000005969 steroid hormone receptors Human genes 0.000 description 1
- 108020003113 steroid hormone receptors Proteins 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 238000004450 types of analysis Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000001086 yeast two-hybrid system Methods 0.000 description 1
Images
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005076974A JP2005237384A (ja) | 2002-03-22 | 2005-03-17 | 新規な全長ｃＤＮＡ |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002137785 | 2002-03-22 | ||
| JP2005076974A JP2005237384A (ja) | 2002-03-22 | 2005-03-17 | 新規な全長ｃＤＮＡ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003157290A Division JP2004008216A (ja) | 2002-03-22 | 2003-03-24 | 新規な全長ｃＤＮＡ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005237384A JP2005237384A (ja) | 2005-09-08 |
| JP2005237384A5 true JP2005237384A5 (fr) | 2005-10-27 |
Family
ID=35019761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005076974A Pending JP2005237384A (ja) | 2002-03-22 | 2005-03-17 | 新規な全長ｃＤＮＡ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005237384A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102332835B1 (ko) | 2013-03-15 | 2021-11-29 | 유니버시티 오브 아이오와 리써치 파운데이션 | 프로모터 조성물 |
-
2005
- 2005-03-17 JP JP2005076974A patent/JP2005237384A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7560541B2 (en) | Heart20049410 full-length cDNA and polypeptides | |
| Nowotschin et al. | Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field | |
| Sobrado et al. | The class I bHLH factors E2-2A and E2-2B regulate EMT | |
| Sansregret et al. | The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase | |
| Reiff et al. | METTL23, a transcriptional partner of GABPA, is essential for human cognition | |
| US20070243176A1 (en) | Human genes and gene expression products | |
| JP2010531662A (ja) | Ｐ５３のモジュレータ及び癌の標的であるｔｒｉｍ２４（ｔｉｆ−１ａ） | |
| Chumakov et al. | Identification of murine and human XCP1 genes as C/EBP-ε-dependent members of FIZZ/Resistin gene family | |
| US20030215803A1 (en) | Human genes and gene expression products isolated from human prostate | |
| Kim et al. | Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer's disease | |
| KR102499713B1 (ko) | 췌장암을 앓는 환자의 생존 예후를 결정하는 방법 | |
| Zhou et al. | Arhgef2 regulates neural differentiation in the cerebral cortex through mRNA m6A-methylation of Npdc1 and Cend1 | |
| JP2005237384A5 (fr) | ||
| Saghizadeh et al. | ZBED4, a BED-type zinc-finger protein in the cones of the human retina | |
| JPWO2002050269A1 (ja) | アレルギー性疾患の検査方法 | |
| JP5378202B2 (ja) | 脳・神経に特異的あるいは神経分化に特異的なバイオマーカー | |
| JP2004008216A (ja) | 新規な全長ｃＤＮＡ | |
| Chen et al. | Biallelic variants in RBM42 cause a multisystem disorder with neurological, facial, cardiac, and musculoskeletal involvement | |
| EP1379651A2 (fr) | Genes humains et produits d'expression genetique isoles de la prostate humaine | |
| US7148011B2 (en) | Method of testing for allergic diseases | |
| JP2005102694A (ja) | 末梢血液細胞に示差的に発現されている遺伝子群、およびそれを用いた診断方法とアッセイ方法 | |
| JP2004261179A (ja) | 新規タンパク質およびそれをコードするｄｎａ | |
| US8309687B2 (en) | Biomarker specific for cancer | |
| JP2005052101A (ja) | 新規タンパク質およびそれをコードするｄｎａ | |
| Barak | Dissecting the molecular genetic basis of juvenile myoclonic epilepsy |